Literature DB >> 11115723

A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction.

R Goethe1, O F Gonzáles, T Lindner, G F Gerlach.   

Abstract

We have characterized antigens from Actinobacillus (A.) pleuropneumoniae grown under iron restriction with respect to their immunogenic and protective potential. Antigens were the cell-free culture supernatants (CFS) obtained after treatment of A. pleuropneumoniae broth cultures with sodium deoxycholate. Using the iron-repressible transferrin-binding lipoprotein TbpB and the constitutively expressed outer membrane lipoprotein OmlA as markers, we have shown that the detergent extraction enriched the CFS with lipoproteins from the outer membrane (OM). Extractions with 0.05% of sodium deoxycholate increased the lipoprotein contents in the CFS, but did not affect the integrity of the OM. This was demonstrated by the absence of the iron-repressible integral OM transferrin-binding protein TbpA. Furthermore, the absence of periplasmic and cytoplasmic proteins in CFS after extraction was determined in immunoblot analyses with anti-bacterial alkaline phosphatase and anti-Hsp60 antisera, demonstrating that there was no rupture of the OMs or the plasma membranes due to the extraction procedure. Antigen preparations from A. pleuropneumoniae serotype 2 and 9 grown under iron restrictive conditions were combined, emulsified, and tested for their ability to confer protection in pigs. Pigs immunized with CFS from sodium deoxycholate extracted cultures developed a strong antibody response and, upon challenge with A. pleuropneumoniae serotype 2, the immunized pigs showed no or only mild clinical signs of disease and had a significantly lower degree of lung damage than the control pigs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115723     DOI: 10.1016/s0264-410x(00)00212-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.

Authors:  Walaiporn Tonpitak; Nina Baltes; Isabel Hennig-Pauka; Gerald F Gerlach
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.

Authors:  Rafael Frandoloso; Sonia Martínez; Elías F Rodríguez-Ferri; María José García-Iglesias; Claudia Pérez-Martínez; Beatriz Martínez-Fernández; César B Gutiérrez-Martín
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

3.  Enzymes involved in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae virulence.

Authors:  Ilse Jacobsen; Isabel Hennig-Pauka; Nina Baltes; Matthias Trost; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.

Authors:  Alexander Maas; Ilse D Jacobsen; Jochen Meens; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 5.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

6.  Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.

Authors:  Xiabing Chen; Zhuofei Xu; Lu Li; Huanchun Chen; Rui Zhou
Journal:  J Microbiol       Date:  2012-12-30       Impact factor: 3.422

7.  Actinobacillus pleuropneumoniae iron transport and urease activity: effects on bacterial virulence and host immune response.

Authors:  N Baltes; W Tonpitak; G F Gerlach; I Hennig-Pauka; A Hoffmann-Moujahid; M Ganter; H J Rothkötter
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.

Authors:  Meili Shao; Yong Wang; Chunlai Wang; Yang Guo; Yonggang Peng; Jiandong Liu; Guangxing Li; Huifang Liu; Siguo Liu
Journal:  Acta Vet Scand       Date:  2010-09-11       Impact factor: 1.695

9.  Identification of dimethyl sulfoxide reductase in Actinobacillus pleuropneumoniae and its role in infection.

Authors:  Nina Baltes; Isabel Hennig-Pauka; Ilse Jacobsen; Achim D Gruber; Gerald F Gerlach
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Analysis of the Actinobacillus pleuropneumoniae ArcA regulon identifies fumarate reductase as a determinant of virulence.

Authors:  Falk F R Buettner; Ibrahim M Bendallah; Janine T Bosse; Karla Dreckmann; John H E Nash; Paul R Langford; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2008-03-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.